High-calorie diet inflates steatogenic effects of valproic acid in mice

References

• Abdelmegeed MA, Yoo S, Henderson LE, et al. (2011). PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J Nutr 141:603–10
   PubMed Web of Science ®Google Scholar
• Adeneye AA, Adeyemi OO. (2009). Further evaluation of antihyperglycaemic activity of Hunteria umbellata (K. Schum) Hallier f. seed extract in experimental diabetes. J Ethnopharmacol 126:238–43
   PubMed Web of Science ®Google Scholar
• Aires CCPL, Stet F, Prip-Buus C, Almeida1 IT, et al. (2009). Inhibition of hepatic Carnitine Palmitoyl-Transferase I (CPT IA) by Valproyl-CoA as a possible mechanism of Valproate-induced steatosis. Biochem Pharmacol 79:792–9
   PubMed Web of Science ®Google Scholar
• Anderson EJ, Yamazaki H, Neufer PD. (2007). Induction of endogenous uncoupling protein 3 suppresses mitochondrial oxidant emission during fatty acid supported respiration. J Biol Chem 282:31257–66
   PubMed Web of Science ®Google Scholar
• Anitha Nandhini AT, Balakrishnan SD, Anuradha CV. (2002). Taurine improves lipid profile in rats fed a high fructose-diet. Nut Res 22:343–54
   Web of Science ®Google Scholar
• Baffy G. (2005). Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci 10:2082–96
   PubMed Web of Science ®Google Scholar
• Balasubramanyam M, Koteswari AA, Kumar RS. (2003). Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J Biosci 28:715–21
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. (1996). The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem 239:70–6
   PubMed Web of Science ®Google Scholar
• Buque X, Martinez MJ, Cano A, et al. (2010). A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. J Lipid Res 51:500–13
   PubMed Web of Science ®Google Scholar
• Desvergne B, Wahli W. (1999). Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649–88
   PubMed Web of Science ®Google Scholar
• El-Mowafy AM, Abdel-Dayem MA, Abdel-Aziz A, et al. (2011). Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility. Biochim Biophys Acta 1811:460–7
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Stanley GSH. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem, 226:497–509
   PubMed Web of Science ®Google Scholar
• Gopaul S, Farrell K, Abbott F. (2003). Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA. Epilepsia 44:322–8
   PubMed Web of Science ®Google Scholar
• Jiang ZY, Hunt JV, Wolf SP. (1992). Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202:384–9
   PubMed Web of Science ®Google Scholar
• Kassahun K, Hu P, Grillo MP, et al. (1994). Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. Chem Biol Interact 90:253–75
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, et al. (2000). Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–10
   PubMed Web of Science ®Google Scholar
• Lee M, Hong Kim M, et al. (2007). Gene expression profiles of murine fatty liver induced by the administration of valproic acid. Toxicol Appl Pharmacol 220:45–59
   PubMed Web of Science ®Google Scholar
• Lombardi A, Busiello RA, Napolitano L, et al. (2010). UCP3 translocates lipid hydroperoxide and mediates lipid hydroperoxide-dependent mitochondrial uncoupling. J Biol Chem 285:16599–605
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
   PubMed Web of Science ®Google Scholar
• Luef G, Rauchenzauner M, Waldmann M, et al. (2009). Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. Epilepsy Res 86:42–7
   PubMed Web of Science ®Google Scholar
• Luef GJ, Waldmann M, Sturm W, et al. (2004). Valproate therapy and non-alcoholic fatty liver disease. Ann Neurol 55:729–32
   PubMed Web of Science ®Google Scholar
• Masuccio F, Verrotti A, Chiavaroli V, et al. (2010). Weight gain and insulin resistance in children treated with valproate: the influence of time. J Child Neurol 25:941–7
   PubMed Web of Science ®Google Scholar
• Mathews DR, Hosker JP, Rudenkl AS, et al. (1985). Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–19
   PubMed Web of Science ®Google Scholar
• Misra A, Singhal N, Khurana L. (2010). Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. J Am Coll Nutr 29:289S–301S
   PubMed Web of Science ®Google Scholar
• Neuman MG, Shear NH, Jacobson-Brown PM, et al. (2001). CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity. Clin Biochem 34:211–18
   PubMed Web of Science ®Google Scholar
• Niehaus WG, Samuelsson B. (1968). Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6:126–30
   PubMedGoogle Scholar
• Roma-Giannikou Syriopoulou V, Kairis M, et al. (1999). In vivo effect of sodium valproate on mouse liver. Cell Mol Life Sci 56:363–9
   PubMed Web of Science ®Google Scholar
• Seifert EL, Bezaire V, Estey C, Harper ME. (2008). Essential role for uncoupling protein-3 in mitochondrial adaptation to fasting but not in fatty acid oxidation or fatty acid anion export. J Biol Chem 283:25124–31
   PubMed Web of Science ®Google Scholar
• Sluse FE, Jarmuszkiewicz W, Navet R, et al. (2006). Mitochondrial UCPs: new insights into regulation and impact. Biochim Biophys Acta 1757:480–5
   PubMed Web of Science ®Google Scholar
• Sobaniec-lotowska ME. (1997). Effects of long-term administration of the antiepileptic drug-sodium valproate upon the ultrastructure of hepatocytes in rats. Exp Toxicol Pathol 49:225–32
   PubMed Web of Science ®Google Scholar
• Sokmen BB, Tunali S, Yanardag R. (2012). Effects of vitamin U (S-methyl methionine sulphonium chloride) on valproic acid induced liver injury in rats. Food Chem Toxicol 50:3562–6
   PubMed Web of Science ®Google Scholar
• Steinberg GR, Kemp BE. (2009). AMPK in health and disease. Physiol Rev 89:1025–78
   PubMed Web of Science ®Google Scholar
• Stewart JD, Horvath R, Baruffini E, et al. (2010). Polymerase γ gene POLG determines the risk of sodium valproate induced liver toxicity. Hepatology 52:1791–6
   PubMed Web of Science ®Google Scholar
• Tong V, Teng XW, Chang TKH, Abbot FS. (2005). Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity and valproic acid metabolite levels in rats. Toxicol Sci 86:427–35
   PubMed Web of Science ®Google Scholar
• Verrotti A, Basciani F, De Simone M, et al. (2002). Insulin resistance in epileptic girls who gain weight after therapy with valproic acid. J Child Neurol 17:256–8
   Web of Science ®Google Scholar
• Verrotti A, Scardapane A, Franzoni E, et al. (2008). Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res 78:171–7
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. (1996). Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–13
   PubMed Web of Science ®Google Scholar
• Wu DF, Clejan L, Potter B, Cederbaum AI. (1990). Rapid decrease of cytochrome P-450IIE1 in primary hepatocyte culture and its maintenance by added 4-methylpyrazole. Hepatology 12:1379–89
   PubMed Web of Science ®Google Scholar
• Zhang L, Chu X, Wang H, et al. (2013). Dysregulations of UDP-glucuronosyl transferases in rats with valproic acid and high fat diet induced fatty liver. Eur J Pharmacol 721:277–85
   PubMed Web of Science ®Google Scholar
• Zhang LF, Liu LS, Chu XM, et al. (2014). Combined effects of a highfat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats. Acta Pharmacol Sin 35:363–72
   PubMed Web of Science ®Google Scholar
• Zimmerman RI, Ishak KG. (1982). Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 2:591–7
   PubMed Web of Science ®Google Scholar